2021-01-07,ADC Therapeutics Initiates Expanded Access Program for Loncastuximab Tesirine in the U.S.
2021-01-04,ADC Therapeutics to Participate in SternIR Virtual Corporate Access Event
2020-12-17,Is ADCT A Good Stock To Buy Now?
2020-12-15,"ADC Therapeutics and Overland Pharma Form Strategic JV to Expand ADC Drugs Development and commercialization in Greater China and Singapore, Advised by MSQ Ventures"
2020-12-14,ADC Therapeutics and Overland Pharmaceuticals Announce Formation of Overland ADCT BioPharma to Develop and Commercialize Lonca and other ADCs for Hematologic and Solid Tumor Indications in Greater China and Singapore
2020-12-07,ADC Therapeutics Announces Updated Clinical Data on Lead Antibody Drug Conjugate Programs Loncastuximab Tesirine (Lonca) and Camidanlumab Tesirine (Cami) Presented at 62nd American Society of Hematology Annual Meeting
2020-11-30,ADC Therapeutics to Host Conference Call Highlighting Data from its Next-Generation Antibody Drug Conjugates Being Presented at the 62nd American Society of Hematology Annual Meeting
2020-11-20,ADC Therapeutics Announces FDA Accepts Biologics License Application and Grants Priority Review for Loncastuximab Tesirine for Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
2020-11-17,Is ADC Therapeutics (NYSE:ADCT) A Risky Investment?
2020-11-12,ADC Therapeutics Reports Third Quarter 2020 Financial Results and Provides Recent Business Highlights
2020-11-12,Adc Therapeutics SA to Host Earnings Call
2020-11-11,Is a Surprise Coming for ADC Therapeutics (ADCT) This Earnings Season?
2020-11-10,ADC Therapeutics to Present at the Stifel 2020 Virtual Healthcare Conference
2020-11-05,Zoetis' (ZTS) Q3 Earnings and Revenues Surpass Estimates
2020-11-05,"bluebird (BLUE) Q3 Loss Narrower Than Expected, Sales Miss"
2020-11-05,"ADC Therapeutics to Host Third Quarter 2020 Financial Results Conference Call on November 12, 2020"
2020-11-04,ADC Therapeutics Announces Eight Presentations on Data from its Next-Generation Antibody Drug Conjugates at the 62nd American Society of Hematology Annual Meeting
2020-11-03,Apellis Pharmaceuticals' (APLS) Q3 Loss Wider Than Expected
2020-11-03,"Bayer's (BAYRY) Q3 Earnings & Sales Miss Estimates, Down Y/Y"
2020-11-03,"Horizon (HZNP) Q3 Earnings Top Estimates, Tepezza Drives Sales"
2020-11-03,ADC Therapeutics Announces First Patient Dosed with Camidanlumab Tesirine (Cami) in Combination with Pembrolizumab in Ongoing Phase 1b Clinical Trial in Selected Solid Tumors
2020-10-30,Genmab and ADC Therapeutics Announce Amended Agreement for Camidanlumab Tesirine (Cami)
2020-10-28,"Ultragenyx (RARE) Loss Narrows Y/Y, Revenues Beat Estimates"
2020-10-09,ADC Therapeutics Announces Full Exercise of Underwriters Option to Purchase Additional Common Shares
2020-10-02,New Ventures Funds Rebrands as Scientia Ventures
2020-09-23,ADC Therapeutics Announces Pricing of Public Offering
2020-09-22,"The Daily Biotech Pulse: Legal Relief For Evolus, Fulgent to Join S&P SmallCap 600, AIM ImmunoTech's Positive Cancer Drug Readout"
2020-09-21,ADC Therapeutics Announces Proposed Public Offering
2020-09-21,ADC Therapeutics Submits Biologics License Application to the U.S. Food and Drug Administration for Loncastuximab Tesirine for Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
2020-09-17,ADC Therapeutics Announces Presentation of Preliminary Findings from Phase 1b Clinical Trial of Camidanlumab Tesirine (Cami) in Advanced Solid Tumors at ESMO Virtual Congress 2020
2020-09-10,ADC Therapeutics Announces Publication Highlighting the Potential of Camidanlumab Tesirine (Cami) as a Novel Immuno-oncology Approach for Solid Tumor Cancers
2020-09-04,ADC Therapeutics Gives Notice of Partial Waiver of Restrictions Pursuant to FINRA Rule 5131
2020-08-20,ADC Therapeutics SA's (NYSE:ADCT) Profit Outlook
2020-08-18,ADC Therapeutics Reports Second Quarter 2020 Financial Results and Provides Recent Business Highlights
2020-08-12,"ADC Therapeutics to Report Second Quarter 2020 Financial Results on August 18, 2020"
2020-07-23,Biotech IPOs Capture Record $7.5 Billion in Second Quarter
2020-07-17,ADC Therapeutics Announces First Patient Dosed in Pivotal Phase 2 Portion of LOTIS 3 Clinical Trial of Loncastuximab Tesirine (Lonca) in Combination With Ibrutinib
2020-07-06,ADC Therapeutics Announces U.S. Food and Drug Administration Has Lifted Partial Clinical Hold on Pivotal Phase 2 Clinical Trial of Camidanlumab Tesirine
2020-06-30,"New Ventures Portfolio Company, ADC Therapeutics, Completes $267 Million IPO"
2020-06-12,ADC Therapeutics Announces Maturing Data from Pivotal Phase 2 Clinical Trial and Phase 1/2 Combination Clinical Trial of Loncastuximab Tesirine (Lonca) in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma
2020-06-05,ADC Therapeutics to Host Conference Call to Highlight Loncastuximab Tesirine (Lonca) Clinical Trial Data Being Presented at Virtual EHA Annual Congress
2020-06-04,Pliant Therapeutics Shares Have Climbed 44% Since This Week's IPO
2020-05-21,ADC Therapeutics Announces Loncastuximab Tesirine (Lonca) Clinical Data to be Presented at the Virtual 25th EHA Annual Congress
2020-05-19,ADC Therapeutics Announces Closing of Upsized $267 Million Initial Public Offering and Receipt of the $65 Million First Tranche under Its $115 Million Convertible Credit Facility with Deerfield
2020-05-15,ADC Therapeutics stock soars 56% in trading debut
2020-05-15,"ADC Therapeutics prices IPO at $19 a share, above the price range"
2020-05-14,ADC Therapeutics Announces Pricing of Upsized Initial Public Offering
2020-05-14,"ADC Therapeutics sets IPO terms, to be valued at up to $1 billion"
